Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · IEX Real-Time Price · USD
3.000
-0.040 (-1.32%)
At close: May 31, 2024, 4:00 PM
2.980
-0.020 (-0.67%)
After-hours: May 31, 2024, 5:15 PM EDT

Relmada Therapeutics Market Cap

Relmada Therapeutics has a market cap or net worth of $90.52 million as of May 31, 2024. Its market cap has decreased by -2.66% in one year.

Market Cap
90.52M
Enterprise Value
6.91M
1-Year Change
-2.66%
Ranking
Category
Stock Price
$3.00

Market Cap Chart

Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $90.52M, an increase of 59.93%. That is a compound annual growth rate of 5.56%.

History

DateMarket Cap% Change
May 31, 202490.50M-1.31%
May 30, 202491.70M3.73%
May 29, 202488.40M-0.67%
May 28, 202489.00M-3.26%
May 24, 202492.00M-1.92%
May 23, 202493.80M0.64%
May 22, 202493.20M-4.70%
May 21, 202497.80M-
May 20, 202497.80M-2.98%
May 17, 2024100.80M-4.27%
May 16, 2024105.30M0.29%
May 15, 2024105.00M-4.37%
May 14, 2024109.80M3.10%
May 13, 2024106.50M-
May 10, 2024106.50M-7.15%
May 9, 2024114.70M-0.78%
May 8, 2024115.60M0.26%
May 7, 2024115.30M-0.77%
May 6, 2024116.20M4.68%
May 3, 2024111.00M-1.07%
May 2, 2024112.20M0.81%
May 1, 2024111.30M1.37%
Apr 30, 2024109.80M3.10%
Apr 29, 2024106.50M-7.87%
Apr 26, 2024115.60M3.58%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Xtant Medical Holdings 93.89M
Sensus Healthcare 93.41M
Assertio Holdings 92.92M
Elutia 92.79M
SCYNEXIS 92.56M
Vor Biopharma 92.29M
Leap Therapeutics 91.83M
SHL Telemedicine 90.64M
Market Cap Rankings